Literature DB >> 12398813

Hypoxia inhibits activin A production by term villous trophoblast in vitro.

M Blumenstein1, M D Mitchell, N P Groome, J A Keelan.   

Abstract

Elevated activin A and inhibin A levels have been associated with pre-eclampsia, a pregnancy-related disorder associated with placental hypoxaemia. We investigated the effect of in vitro hypoxia on the production of inhibin A, activin A and its binding protein follistatin in term villous placental explants (n=4-7) and trophoblast monolayer cultures (n=4). Explants and trophoblasts were incubated for 24-72 h under either normoxic (21 per cent O(2)) or hypoxic (2 per cent O(2)) conditions. Production of activin A, inhibin A, and follistatin was determined by specific ELISA. After 48 h of hypoxia, villous explants exhibited a significant reduction in activin A production rates to 53.2 +/- 8.9 per cent (mean +/- SEM, P<0.05) of normoxic controls which was sustained after 72 h in culture (46.8 +/- 5.9 per cent), whereas production by trophoblast monolayers was not affected by hypoxia. Follistatin production was decreased to 53.7 +/- 9.2 per cent of control (P<0.05) after 48 h of hypoxia. Inhibin A production remained unaltered in both culture systems. Our data demonstrate for the first time that hypoxia lowers term placental activin A and follistatin production in vitro. These findings do not support the notion that elevated circulating activin A levels in pre-eclampsia originate from the placenta as a result of placental hypoxia. Other as yet unknown maternal/placental factors may contribute to elevated activin A production in women with severe pre-eclampsia. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12398813     DOI: 10.1016/s0143-4004(02)90868-4

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  3 in total

1.  Expression of inhibin/activin subunits alpha (-alpha), betaA (-betaA), and betaB (-betaB) in placental tissue of normal, preeclamptic, and HELLP pregnancies.

Authors:  I Mylonas; B Schiessl; U Jeschke; J Vogl; A Makrigiannakis; C Kuhn; S Schulze; F Kainer; K Friese
Journal:  Endocr Pathol       Date:  2006       Impact factor: 3.943

Review 2.  Neurokinin B and pre-eclampsia: a decade of discovery.

Authors:  Nigel M Page
Journal:  Reprod Biol Endocrinol       Date:  2010-01-14       Impact factor: 5.211

3.  Transfusion-related adverse events are decreased in pregnant women with sickle cell disease by a change in policy from systematic transfusion to prophylactic oxygen therapy at home: A retrospective survey by the international sickle cell disease observatory.

Authors:  Jean-Antoine Ribeil; Myriam Labopin; Aurélie Stanislas; Benjamin Deloison; Delphine Lemercier; Anoosha Habibi; Souha Albinni; Caroline Charlier; Olivier Lortholary; François Lefrere; Mariane De Montalembert; Stéphane Blanche; Frédéric Galactéros; Jean-Marc Tréluyer; Eliane Gluckman; Yves Ville; Laure Joseph; Marianne Delville; Alexandra Benachi; Marina Cavazzana
Journal:  Am J Hematol       Date:  2018-04-17       Impact factor: 10.047

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.